A new plant-based drug delivery platform based on alkyl polyglucosides and β-sitosterol nanovesicles for topical delivery

• Novel nanovesicles without animal-derived components have been developed. • These stable nanovesicles are formed by the self-assembly of β-sitosterol, lauryl glucoside and lauryl glucose carboxylate using the single-step DELOS methodology. • Tocopherol as a hydrophobic model molecule is efficiently loaded in the nanovesicles (49 ± 12 %) maintaining its antioxidant function. • This new nanovesicles are biocompatible with the skin, as evaluated in a 3D epidermal in vitro model. • They enhance the ex vivo skin permeation of a hydrophobic fluorescent probe in terms of time and depth through the epidermis. The finding of new vesicular systems is a challenging process that depends on different factors such as the components used, the interactions between them or the dispersant media. Our objective was to develop a new vesicular delivery system formed by self-assembly of β-Sitosterol (Sit), Lauryl Glucoside (LGL) and Lauryl Glucose Carboxylate (LGC) molecules, all plant-based, biodegradable and biocompatible components. Nanovesicles (NVs) with different molar ratios of Sit, LGL and LGC were prepared using a single step method named DELOS, and characterized by dynamic light scattering, cryo-electron microscopy and small-angle X-ray scattering. Antioxidant compound α-tocopherol (TCP) was integrated in the NVs showing their potential to nanoformulate hydrophobic payloads. Finally, in vitro biocompatibility assays with reconstructed human epidermis and ex vivo skin retention studies using multiphoton microscopy and NVs labelled with Nile Red (NR) were carried out. As a result of this work, a new platform of NVs has been obtained by the self-assembly of Sit, LGL and LGC, obtaining vesicular systems with tunable physicochemical properties in terms of size (130 – 220 nm), surface charge ((-70) – (-40) mV) and lamellarity (unilamellar and multilamellar vesicles), when the carbon chain of the alkyl polyglucoside was >12. The vesicles could efficiently integrate TCP, proving their potential role as delivery systems and maintaining its antioxidant activity after loading. Finally, they also showed biocompatibility with the skin and improved the permeability of the poorly water-soluble molecule NR in terms of time and depth through the epidermis. Overall, the results of this work point to the successful development of an attractive platform based on stable and homogeneous nanovesicles composed of plant-derived ingredients for topical delivery.

Authors

Institutions

Publication Details

Journal
Applied Materials Today
Published
2024-10-18
DOI
https://doi.org/10.1016/j.apmt.2024.102467
Citations
3
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.62

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A new plant-based drug delivery platform based on alkyl polyglucosides and β-sitosterol nanovesicles for topical delivery

Silvia Pescina, Cristina Sissa, Lidia Ferrer‐Tasies, Ilaria Ferraboschi et al.
3 citations
Applied Materials Today
Advancements in Transdermal Drug Delivery
0.62
article

A new plant-based drug delivery platform based on alkyl polyglucosides and β-sitosterol nanovesicles for topical delivery

Silvia Pescina, Cristina Sissa, Lidia Ferrer‐Tasies, Ilaria Ferraboschi, Alba Córdoba, Annalisa Bianchera, Nora Ventosa, Marta Alcaina-Hernando, Jan Skov Pedersen, Cristián Huck‐Iriart, Ivana Malvacio, Santi Sala
article en
3 citations

Abstract

• Novel nanovesicles without animal-derived components have been developed. • These stable nanovesicles are formed by the self-assembly of β-sitosterol, lauryl glucoside and lauryl glucose carboxylate using the single-step DELOS methodology. • Tocopherol as a hydrophobic model molecule is efficiently loaded in the nanovesicles (49 ± 12 %) maintaining its antioxidant function. • This new nanovesicles are biocompatible with the skin, as evaluated in a 3D epidermal in vitro model. • They enhance the ex vivo skin permeation of a hydrophobic fluorescent probe in terms of time and depth through the epidermis. The finding of new vesicular systems is a challenging process that depends on different factors such as the components used, the interactions between them or the dispersant media. Our objective was to develop a new vesicular delivery system formed by self-assembly of β-Sitosterol (Sit), Lauryl Glucoside (LGL) and Lauryl Glucose Carboxylate (LGC) molecules, all plant-based, biodegradable and biocompatible components. Nanovesicles (NVs) with different molar ratios of Sit, LGL and LGC were prepared using a single step method named DELOS, and characterized by dynamic light scattering, cryo-electron microscopy and small-angle X-ray scattering. Antioxidant compound α-tocopherol (TCP) was integrated in the NVs showing their potential to nanoformulate hydrophobic payloads. Finally, in vitro biocompatibility assays with reconstructed human epidermis and ex vivo skin retention studies using multiphoton microscopy and NVs labelled with Nile Red (NR) were carried out. As a result of this work, a new platform of NVs has been obtained by the self-assembly of Sit, LGL and LGC, obtaining vesicular systems with tunable physicochemical properties in terms of size (130 – 220 nm), surface charge ((-70) – (-40) mV) and lamellarity (unilamellar and multilamellar vesicles), when the carbon chain of the alkyl polyglucoside was >12. The vesicles could efficiently integrate TCP, proving their potential role as delivery systems and maintaining its antioxidant activity after loading. Finally, they also showed biocompatibility with the skin and improved the permeability of the poorly water-soluble molecule NR in terms of time and depth through the epidermis. Overall, the results of this work point to the successful development of an attractive platform based on stable and homogeneous nanovesicles composed of plant-derived ingredients for topical delivery.

Applied Materials TodayVol. 41
University of Parma (IT), Aarhus University (DK), Instituto de Salud Carlos III (ES), ALBA Synchrotron (Spain) (ES), Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES), Centre de Recerca Matemàtica (ES), Institut de Ciència de Materials de Barcelona (ES)
Dipartimenti di Eccellenza, European Commission, Generalitat de Catalunya, Ministero dell’Istruzione, dell’Università e della Ricerca, Ministerio de Ciencia e Innovación, Agència per a la Competitivitat de l’Empresa
Openalex Percentile: Top 36%
Advancements in Transdermal Drug Delivery
0.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.